Summary

  • A report by Longevity.Technology has found that around 320 commercial “longevity” treatment clinics currently operate worldwide, with the majority offering prescription medications and over a third offering unproven stem cell therapies, with no proof they extend life or are without risk.
  • Most clinics also offer aesthetic treatments and are largely targeting patients in their 40s and 50s, the findings align with anecdotal evidence that it is around this time that many people start to feel the effects of ageing.
  • Clinics marketing themselves as offering “longevity” therapies charge between 150,000 per annum, however, fewer than half of them are turning a profit.
  • Proponents of the treatment say they represent the future of medicine, offering proactive health maintenance rather than reactive treatments, although the report highlights the need for the field to become more robust.

By Jessica Hamzelou

Original Article